Growth factor insensitivity in renal failure

Renal Failure

Volumn 23, Issue 3-4, 2001, Pages 291-300

  Rabkin, R ^a  

^a VA PALO ALTO HEALTH CARE SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GROWTH HORMONE; INSULIN; RECOMBINANT GROWTH FACTOR; SOMATOMEDIN;

CHRONIC KIDNEY FAILURE; CONFERENCE PAPER; DIALYSIS; DISEASE ASSOCIATION; DRUG MECHANISM; DRUG SENSITIVITY; ENDOCRINE DISEASE; HUMAN; INSULIN RESISTANCE; METABOLIC DISORDER; NUTRITIONAL STATUS; PRIORITY JOURNAL; SIDE EFFECT;

ANIMALS; GROWTH HORMONE; GROWTH SUBSTANCES; HUMANS; INSULIN; INSULIN RESISTANCE; INSULIN-LIKE GROWTH FACTOR I; KIDNEY FAILURE, CHRONIC;

EID: 0034915393     PISSN: 0886022X     EISSN: None     Source Type: Journal    
DOI: 10.1081/JDI-100104713     Document Type: Conference Paper

References (32)

1. Carbohydrate and insulin metabolism in renal failure
2. Renal disease, insulin resistance, and glucose intolerance
3. Glucose metabolism in non-diabetic and insulin-dependent diabetic subjects with end-stage renal failure
4. Effect of prolonged uremia on insulin metabolism by isolated liver and muscle
5. Muscle insulin resistance in uremic humans: Glucose transport, glucose transporters, and insulin receptors
6. Insulin resistance in uremia: Characterization of insulin action, binding, and processing in isolated hepatocytes from chronic uremic rats
7. Insulin-like growth factor-1 action on glucose transport in acute renal failure
8. Therapeutic approaches to malnutrition in chronic dialysis patients: The different modalities of nutritional support
9. Growth hormone and insulin-like factor in non-uremic acidosis and uremic acidosis
10. Effects of recombinant human growth hormone on muscle protein turnover in malnourished hemodialysis patients
11. Derangements of the somatotropic hormone axis in chronic renal failure
12. Increased mortality associated with growth hormone treatment in critically ill adults
13. Growth hormone therapy in critically ill patients
14. Response to growth hormone-releasing hormone in adult renal failure patients on hemodialysis
15. Factors predicative of the short- and long-term efficacy of growth hormone treatment in prepubertal children with chronic renal failure
16. Insulin-like growth factor system and the kidney: Physiology, pathophysiology, and therapeutic implications
17. End-organ resistance to growth hormone and IGF-I in epiphyseal chondrocytes of rats with chronic renal failure
18. Response to growth hormone therapy in experimental ischemic acute renal failure
19. The mechanisms by which growth hormone brings about growth. The relative contributions of growth hormone and insulin-like growth factors
20. Growth hormone binding protein and free growth hormone in chronic renal failure
21. Reduced concentration of serum growth hormone (GH)-binding protein in children with CRF: Correlation with GH insensitivity
22. The insulin-like growth factor axis and growth in children with chronic renal failure: A Report of the southwest Pediatric Nephrology Study Group
23. Nutrient regulation of IGF-I. Mineral and electrolyte
24. Reduced food intake is the main cause of low GHR expression in uremic rats
25. Growth hormone resistance and inhibition of somatomedin activity by excess of insulin-like growth factor binding protein in uremia
26. Early experience with extended use of insulin-like growth factor-1 in the treatment of advanced chronic renal failure: Effect on renal function and insulin-like growth factor binding proteins
27. Impaired actions of insulin-like growth factor 1 on protein synthesis and degradation in skeletal muscle of rats with CRF
28. IGF-I receptor binding, autophosphorylation, and kinase activity in kidney and muscle of acutely uremic rats
29. Reduced food intake is the main cause of low GHR expression in uremic rats
30. Impaired metabolic response to recombinant insulin-like growth factor 1 in dialysis patients
31. Effects of IGF-1 on renal function in end-stage chronic renal failure
32. Insulin-like growth factor 1 improves renal function in patients with end-stage chronic renal failure